Cargando…

Immunosuppressive Drugs and COVID-19: A Review

BACKGROUND: Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It is currently unknown whether immunosuppressive drugs are advantageous or detrimental in patients with COVID-19. Immunosuppressive drugs could be harmful in the initial phase...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schoot, Tessa S., Kerckhoffs, Angèle P. M., Hilbrands, Luuk B., van Marum, Rob J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485413/ https://www.ncbi.nlm.nih.gov/pubmed/32982743 http://dx.doi.org/10.3389/fphar.2020.01333

Ejemplares similares

Dialysis or kidney transplantation in older adults? A systematic review summarizing functional, psychological, and quality of life-related outcomes after start of kidney replacement therapy
por: Schoot, Tessa S., et al.
Publicado: (2022)

Kidney transplantation or dialysis in older adults—an interview study on the decision-making process
por: Schoot, Tessa S, et al.
Publicado: (2022)

Calming the Storm: Natural Immunosuppressants as Adjuvants to Target the Cytokine Storm in COVID-19
por: Peter, Angela E., et al.
Publicado: (2021)

CKD is a key risk factor for COVID-19 mortality
por: Gansevoort, Ron T., et al.
Publicado: (2020)

COVID-19 Incidence in Patients With Immunomediated Inflammatory Diseases: Influence of Immunosuppressant Treatments
por: Soldevila-Domenech, Natalia, et al.
Publicado: (2020)

Immunosuppressant drugs and quality-of-life outcomes in kidney transplant recipients: An international cohort study (EU-TRAIN)
por: Girardin, François R., et al.
Publicado: (2023)

Registered report protocol: A scoping review to identify potential predictors as features for developing automated estimation of the probability of being frail in secondary care
por: van Dalen, Dirk H., et al.
Publicado: (2022)

Advances in Immunosuppressive Agents Based on Signal Pathway
por: Xu, Zhiqing, et al.
Publicado: (2022)

Montelukast Drug May Improve COVID-19 Prognosis: A Review of Evidence
por: Barré, Jean, et al.
Publicado: (2020)

Efficacy of the current investigational drugs for the treatment of COVID-19: a scoping review
por: Wadaa-Allah, Ahmed, et al.
Publicado: (2021)

Immunosuppressive Activity of Artemisia argyi Extract and Isolated Compounds
por: Zimmermann-Klemd, Amy M., et al.
Publicado: (2020)

Expert-Augmented Computational Drug Repurposing Identified Baricitinib as a Treatment for COVID-19
por: Smith, Daniel P., et al.
Publicado: (2021)

The Coincidence Between Increasing Age, Immunosuppression, and the Incidence of Patients With Glioblastoma
por: Ladomersky, Erik, et al.
Publicado: (2019)

Editorial: Drug Repurposing for COVID-19 Therapy
por: Maldonado, Rafael, et al.
Publicado: (2021)

An Italian multicentre distributed data research network to study the use, effectiveness, and safety of immunosuppressive drugs in transplant patients: Framework and perspectives of the CESIT project
por: Belleudi, Valeria, et al.
Publicado: (2022)

Oncological Impact of M-Tor Inhibitor Immunosuppressive Therapy after Liver Transplantation for Hepatocellular Carcinoma: Review of the Literature
por: Tarantino, Giuseppe, et al.
Publicado: (2016)

Challenges for Drug Repurposing in the COVID-19 Pandemic Era
por: Sultana, Janet, et al.
Publicado: (2020)

Adverse Cardiovascular Effects of Anti-COVID-19 Drugs
por: Liu, Dongling, et al.
Publicado: (2021)

Immunosuppressive Effects of Natural α,β-Unsaturated Carbonyl-Based Compounds, and Their Analogs and Derivatives, on Immune Cells: A Review
por: Arshad, Laiba, et al.
Publicado: (2017)

Steroidal Alkaloids as an Emerging Therapeutic Alternative for Investigation of Their Immunosuppressive and Hepatoprotective Potential
por: Jan, Naeem U., et al.
Publicado: (2017)

Immunosuppressive Isopimarane Diterpenes From Cultures of the Endophytic Fungus Ilyonectria robusta
por: Ye, Ke, et al.
Publicado: (2022)

Cancer-associated fibroblast infiltration in osteosarcoma: the discrepancy in subtypes pathways and immunosuppression
por: Zhihao, Zhang, et al.
Publicado: (2023)

A Repurposed Drug Screen Identifies Compounds That Inhibit the Binding of the COVID-19 Spike Protein to ACE2
por: Tsegay, Kaleb B., et al.
Publicado: (2021)

Repurposing Anti-Malaria Phytomedicine Artemisinin as a COVID-19 Drug
por: Uckun, Fatih M., et al.
Publicado: (2021)

Household Drug Stockpiling and Panic Buying of Drugs During the COVID-19 Pandemic: A Study From Jordan
por: Al Zoubi, Sura, et al.
Publicado: (2021)

Drug-Induced Liver Disturbance During the Treatment of COVID-19
por: Zhai, Guanghua, et al.
Publicado: (2021)

Co-Targeting Tumor Angiogenesis and Immunosuppressive Tumor Microenvironment: A Perspective in Ethnopharmacology
por: Zhou, Jianbo, et al.
Publicado: (2022)

Immunomodulatory Effect of Ginsenoside Rb2 Against Cyclophosphamide-Induced Immunosuppression in Mice
por: Zheng, Siwen, et al.
Publicado: (2022)

Host and immunosuppression-related factors influencing fibrosis occurrence post liver transplantation
por: Iacob, Speranta, et al.
Publicado: (2022)

Efficacy and safety profile of corticosteroids and non-steroidal anti-inflammatory drugs in COVID-19 management: A narrative review
por: Amponsah, Seth Kwabena, et al.
Publicado: (2022)

The perspectives of patients with lithium-induced end-stage renal disease
por: Kerckhoffs, Angèle P. M., et al.
Publicado: (2018)

Molecular Mechanism of Action of Repurposed Drugs and Traditional Chinese Medicine Used for the Treatment of Patients Infected With COVID-19: A Systematic Scoping Review
por: Lem, Fui Fui, et al.
Publicado: (2021)

Psychotropic drugs interaction with the lipid nanoparticle of COVID-19 mRNA therapeutics
por: Sfera, Adonis, et al.
Publicado: (2022)

Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19
por: Saha, Rudra P., et al.
Publicado: (2020)

Prevention of Cyclophosphamide-Induced Immunosuppression in Mice With Traditional Chinese Medicine Xuanfei Baidu Decoction
por: Yan, Huimin, et al.
Publicado: (2021)

Metabolomic Profiling and Immunomodulatory Activity of a Polyherbal Combination in Cyclophosphamide-Induced Immunosuppressed Mice
por: Zahiruddin, Sultan, et al.
Publicado: (2022)

Fluvoxamine: A Review of Its Mechanism of Action and Its Role in COVID-19
por: Sukhatme, Vikas P., et al.
Publicado: (2021)

Therapeutic Effectiveness and Safety of Repurposing Drugs for the Treatment of COVID-19: Position Standing in 2021
por: Alam, Safaet, et al.
Publicado: (2021)

Rapamycin: A Bacteria-Derived Immunosuppressant That Has Anti-atherosclerotic Effects and Its Clinical Application
por: Liu, Yandong, et al.
Publicado: (2019)

Efficacy and Safety of Immunosuppressive Monotherapy Agents for IgA Nephropathy: A Network Meta-Analysis
por: Han, Shisheng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_anh9ugr3guobgrpgqc4s52u2am